Article

Potent immunogenicity and protective efficacy of a multi-pathogen vaccination targeting Zaire ebolavirus, Sudan ebolavirus, Marburg and Lassa viruses

2023-11-05

Abstract excerpt

Viral haemorrhagic fevers (VHF) pose a significant threat to human health. In recent years, VHF outbreaks caused by Ebola, Marburg and Lassa viruses have caused substantial morbidity and mortality in West and Central Africa. In 2022, an Ebola disease outbreak in Uganda caused by Sudan ebolavirus resulted in 164 cases with 55 deaths. In February 2023, a Marburg disease outbreak was confirmed in Equatorial Guinea re...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2501dfe9-e25f-5290-8ade-14c4a4a1e585
DOI: 10.1101/2023.11.03.565549

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Potent immunogenicity and protective efficacy of a multi-pathogen vaccination targeting Zaire ebolavirus, Sudan ebolavirus, Marburg and Lassa virusesDOI 10.1101/2023.11.03.565549Read

Simultaneous broad protection against Ebola Sudan, Marburg and Lassa viruses conferred by a DNA primed MVA-vectored multivalent vaccineSemantic proximity Read

A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challengeSemantic proximity Read

Induction of Broad Cytotoxic T Cells by Protective DNA Vaccination Against Marburg and EbolaSemantic proximity Read

Rapid and Durable Protection Against Marburg Virus with a Single-Shot ChAd3-MARV GP VaccineSemantic proximity Read

Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 ProteinsSemantic proximity Read

Challenges, Progress, and Pathways to Equitable ACCESS in Lassa Fever Vaccine DevelopmentSemantic proximity Read

Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trialsSemantic proximity Read

Filoviridae: Insights into Immune Responses to EbolavirusSemantic proximity Read

Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteinsSemantic proximity Read

Expert Review of Global Real-World Data on COVID-19 Vaccine Booster Effectiveness & Safety During the Omicron-dominant Phase of the PandemicSemantic proximity Read

The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platformSemantic proximity Read

Safety and Immunogenicity of DNA Vaccines Encoding Ebolavirus and Marburgvirus Wild-Type Glycoproteins in a Phase I Clinical TrialSemantic proximity Read